Utilization of evidence-based secondary prevention medications at the time of discharge in patients with acute coronary syndrome (ACS) in Qatar.

CONCLUSION: Most ACS patients were prescribed antiplatelets, β-blockers and statins, but the use of ACEIs or ARBs was suboptimal. Strategies are needed to enhance ACEI or ARB prescribing, especially for high risk patients who would have the greatest therapeutic benefit from these drugs.
PMID: 26916397 [PubMed - as supplied by publisher]

Source: Current Vascular Pharmacology - February 26, 2016 Category: Drugs & Pharmacology Authors: El Hajj MS, Saad A, Suwaidi JA, Al Marridi WF, Elkhalifa DH, Mohamed A, Mahfoud ZR Tags: Curr Vasc Pharmacol Source Type: research